VAERS Explorer
Back to explore

Report #2895320

Received May 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
12 yrs
State
CA
Recovered
Unknown
Vaccinated
Feb 20, 2026
Onset
Feb 20, 2026
Days to onset
0
Hospital days

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1Y020531IM / LA
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1Y020531OT / LA

Symptoms (2)

Product storage issueNo adverse event

Symptom narrative

No symptomatic events were reported; temperature excursion/the medication error occurred; This spontaneous report has been received from a medical assistant and refers to a 12-year-old male patient. The patient's concurrent conditions included hypercholesterolemia. The patient's historical conditions, past medications and concomitant medications were not reported. On 20-FEB-2026, the patient was vaccinated with 1st dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection (batch/lot number Y020531, confirmed valid with an expiry date of 05-AUG-2027) administered intramuscularly into the left arm for prophylaxis (exact dose was not reported). Before administration, the vaccine underwent temperature excursion; it was reported that a medication error occurred (Product storage error). No symptomatic events were reported (No adverse event). This is one of several reports received from the same reporter.

Current illness

Hypercholesterolemia